New product: Xeljanz (tofacitinib) 11 mg prolonged release tablets

This product is licensed in combination with methotrexate (MTX) for moderate-severe RA in adults who have responded inadequately to or who are intolerant to one or more DMARD. It can be given as monotherapy in case of intolerance to MTX or when treatment with MTX is inappropriate

electronic Medicines compendium